These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3021350)
1. Design and synthesis of N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L -alanyl]-N-(indan-2-yl)glycine (CV-3317), a new, potent angiotensin converting enzyme inhibitor. Miyake A; Itoh K; Oka Y Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2852-8. PubMed ID: 3021350 [No Abstract] [Full Text] [Related]
2. Synthesis and angiotension converting enzyme inhibitory activity of L-lysyl-N-substituted glycine derivatives. Saito S; Matsui S; Fukushima S; Watanabe M; Waga T; Kajiwara Y; Shirota M; Iijima M; Kitabatake K Arzneimittelforschung; 1989 Dec; 39(12):1558-61. PubMed ID: 2560371 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound. Inada Y; Terashita Z; Imura Y; Tanabe M; Nishikawa K; Kikuchi S Jpn J Pharmacol; 1986 Sep; 42(1):99-108. PubMed ID: 3025487 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models. Inada Y; Tanabe M; Shibouta Y; Kawazoe K; Nishikawa K; Kikuchi S Jpn J Pharmacol; 1986 Sep; 42(1):1-8. PubMed ID: 3025485 [TBL] [Abstract][Full Text] [Related]
5. [Synthesis and antiplatelet aggregating activity of several thiopyranylidene ketones and benzylidene indanones]. Varache-Beranger M; Nuhrich A; Devaux G Farmaco Sci; 1987 Jun; 42(6):465-73. PubMed ID: 3653390 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of a highly active angiotensin converting enzyme inhibitor: 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498). Teetz V; Geiger R; Henning R; Urbach H Arzneimittelforschung; 1984; 34(10B):1399-401. PubMed ID: 6097264 [TBL] [Abstract][Full Text] [Related]
7. Pharmacologically active derivatives of geminally dialkylated indenes and indans. II. Synthesis and pharmacological screening of some 3-amino-alkyl-1-,1-dialkylindenes and 1-aminoalkylidene-3-3-dialkylindans, potent reserpine antagonists. Jönsson NA; Merényi F; Dahlander B; Sparf B Acta Pharm Suec; 1979; 16(3):173-86. PubMed ID: 484250 [No Abstract] [Full Text] [Related]
8. Pharmacologically active derivatives of geminally dialkylated indenes and indans. I. O-aminoalkyl ethers of 3,3-dialkyl-1-hydroxyimmunoindans. Jönsson NA; Merényi F; Dahlander B Acta Pharm Suec; 1978; 15(6):406-18. PubMed ID: 749545 [No Abstract] [Full Text] [Related]
9. Synthesis and pharmacological activities of some 2,3-substituted bicyclo[3.3.0]oct-7-en-1-one and 2,3-substituted 4,5,6,7-tetrahydro (or perhydro) indan-1-one derivatives. Brancaccio G; Lettieri G; Monforte P; Larizza A Farmaco Sci; 1983 Sep; 38(9):702-8. PubMed ID: 6641935 [TBL] [Abstract][Full Text] [Related]
10. 1-Indancarboxylic acids. I. Electrophilic substitution reactions of 1-indancarboxylic acid and synthesis of 6-substituted 1-indancarboxylic acids as potential antinflammatory agents. Aono T; Kishimoto S; Araki Y; Noguchi S Chem Pharm Bull (Tokyo); 1977 Dec; 25(12):3198-209. PubMed ID: 608223 [No Abstract] [Full Text] [Related]
11. Synthesis and antianxiety activity of (omega-piperazinylalkoxy)indan derivatives. Kikumoto R; Tobe A; Fukami H; Egawa M J Med Chem; 1983 Feb; 26(2):246-50. PubMed ID: 6131132 [TBL] [Abstract][Full Text] [Related]
12. Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries. Moroi M; Akatsuka N; Fukazawa M; Hara K; Ishikawa M; Aikawa J; Namiki A; Yamaguchi T Am J Physiol; 1994 Feb; 266(2 Pt 2):H583-9. PubMed ID: 8141360 [TBL] [Abstract][Full Text] [Related]
13. (Acylaryloxy)acetic acid diuretics. 5. [(2-Alkyl- and 2,2-disubstituted-1,3-dioxo-5-indanyl)oxy]acetic acids. Woltersdorf OW; deSolms SJ; Stokker GE; Cragoe EJ J Med Chem; 1984 Jul; 27(7):840-5. PubMed ID: 6737427 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological properties of N-arylpiperazine-N'-alkylindanes. Misztal S; Chojnacka-Wójcik E; Bartyzel P; Moskal A; Tatarczyńska E; Wiczyńska B; Lewandowska A Pol J Pharmacol Pharm; 1984; 36(6):697-703. PubMed ID: 6336001 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of the estrogenic activity of stilbestrol by spiro (cyclohexane-1,2'-indan)-1',4-dione. Bailey DJ; Doggett NS; Ng LY; Qazi T J Med Chem; 1976 Mar; 19(3):438-9. PubMed ID: 1255671 [TBL] [Abstract][Full Text] [Related]